Inventor · disambiguated record
Laurence J. Marton
Also filed as: BASU HIRAK S · CLIFFORD LEGAL REPRESENTATIVE · MARTON LAURENCE · MARTON LAURENCE J
20 granted patents·12 pending applications·527 citations·filing 1993–2011
96Inventor score
Files withCELLGATE INC7SLIL BIOMEDICAL CORP7WISCONSIN ALUMNI RES FOUND4FRYDMAN BENJAMIN3MARTON LAURENCE J3
Top patents by PatentIndex Score
32 records- 0194US6982351B2Cycloalkyl substituted polyamines for cancer therapy and methods of synthesis thereforCELLGATE INC·Filed 2002·Granted Jan 3, 2006·38 cites·11 claims
- 0294US5541230ATherapeutic polyaminesUS HEALTH·Filed 1993·Granted Jul 30, 1996·77 cites·2 claims
- 0393US6809176B2Quinones as disease therapiesSLIL BIOMEDICAL CORP·Filed 2002·Granted Oct 26, 2004·40 cites·8 claims
- 0492US7453011B2Cycloalkyl substituted polyamines for cancer therapy and methods of synthesis thereforPROGEN PHARMACEUTICALS INC·Filed 2007·Granted Nov 18, 2008·17 cites·14 claims
- 0592US7312244B2Polyamine analog-amino acid conjugates useful as anticancer agentsCELLGATE INC·Filed 2001·Granted Dec 25, 2007·28 cites·24 claims
- 0691US7279502B2Polyamine analog conjugates and quinone conjugates as therapies for cancers and prostate diseasesCELLGATE INC·Filed 2004·Granted Oct 9, 2007·31 cites·6 claims
- 0791US7235695B2Cycloalkyl substituted polyamines for cancer therapy and methods of synthesis thereforFRYDMAN BENJAMIN·Filed 2005·Granted Jun 26, 2007·17 cites·26 claims
- 0891US6482943B1Quinones as disease therapiesSLIL BIOMEDICAL CORP·Filed 2000·Granted Nov 19, 2002·26 cites·1 claims
- 0990US6649587B1Polyamine analog conjugates and quinone conjugates as therapies for cancers and prostate diseasesSLIL BIOMEDICAL CORP·Filed 2000·Granted Nov 18, 2003·27 cites·20 claims
- 1090US5889061AConformationally restricted polyaminesWISCONSIN ALUMNI RES FOUND·Filed 1997·Granted Mar 30, 1999·48 cites·24 claims
- 1190US5880161ATherapeutic polyaminesUS HEALTH·Filed 1996·Granted Mar 9, 1999·48 cites·11 claims
- 1286US6392098B1Conformationally restricted polyaminesWISCONSIN ALUMNI RES FOUND·Filed 1999·Granted May 21, 2002·28 cites·22 claims
- 1385US6794545B1Conformationally restricted polyamine analogs as disease therapiesSLIL BIOMEDICAL CORP·Filed 2000·Granted Sep 21, 2004·20 cites·20 claims
- 1484US7253207B2Quinones as disease therapiesCELLGATE INC·Filed 2004·Granted Aug 7, 2007·11 cites·21 claims
- 1584US7198946B2Screening for agents effective in decreasing abnormal macrophages associated with amyotrophic lateral sclerosisPATHOLOGICA LLC·Filed 2002·Granted Apr 3, 2007·16 cites·3 claims
- 1684US7186825B2Conformationally restricted polyamine analogs as disease therapiesCELLGATE INC·Filed 2004·Granted Mar 6, 2007·15 cites·20 claims
- 1783US7026347B2Porphyrin-polyamine conjugates for cancer therapyCELLGATE INC·Filed 2003·Granted Apr 11, 2006·14 cites·16 claims
- 1876US5883270A4-substituted-1, 2-naphthoquinones and their use in the inhibition of neoplastic cell growthWISCONSIN ALUMNI RES FOUND·Filed 1996·Granted Mar 16, 1999·16 cites·1 claims
- 1965US5977187A4-substituted-1,2-naphthoquinones and their use in the inhibition of neoplastic cell growthWISCONSIN ALUMNI RES FOUND·Filed 1998·Granted Nov 2, 1999·9 cites·10 claims
- 2060US2009124832A1Oligoamine compounds and derivatives thereof for cancer therapyPROGEN PHARMACEUTICALS INC·Filed 2009·Application pending·0 cites
- 2159US2008194697A1Novel polyamine analog conjugates and quinone conjugates as therapies for cancers and prostate diseasesFRYDMAN BENJAMIN·Filed 2007·Application pending·0 cites
- 2257US2007161692A1Conformationally restricted polyamine analogs as disease therapiesCELLGATE INC·Filed 2006·Application pending·0 cites
- 2356US7491849B2Oligoamine compounds and derivatives thereof for cancer therapyPROGEN PHARMACEUTICALS INC·Filed 2004·Granted Feb 17, 2009·1 cites·21 claims
- 2454US2004006049A1Novel polyamine analog conjugates and quinone conjugates as therapies for cancers and prostate diseasesSLIL BIOMEDICAL CORP·Filed 2003·Application pending·0 cites
- 2546US2006276444A1Porphyrin-polyamine conjugates for cancer therapyFRYDMAN BENJAMIN·Filed 2006·Application pending·0 cites
- 2646US2003130356A1Oligoamine compounds and derivatives thereof for cancer therapySLIL BIOMEDICAL CORP·Filed 2002·Application pending·0 cites
- 2744US2004192665A1Conjugates of porphyrin compounds with chemotherapeutic agentsSLIL BIOMEDICAL CORP·Filed 2003·Application pending·0 cites
- 2844US2007232677A1Treatment and prevention of vascular hyperplasia using polyamine and polyamine analog compoundsMARTON LAURENCE J·Filed 2007·Application pending·0 cites
- 2943US2009143456A1Polyamine Analogs as Modulators of Cell Migration and Cell MotilityMARTON LAURENCE J·Filed 2006·Application pending·0 cites
- 3039US2013197088A1Compositions and Methods for Combinations of Oligoamines with 2-Difluoromethylornithine (DFMO)CASERO JR ROBERT A·Filed 2011·Application pending·0 cites
- 3138US2006160906A1Polyamine analogs as therapeutic agents for ocular diseasesMARTON LAURENCE J·Filed 2005·Application pending·0 cites
- 3232US2013102556A1Use of N1,N4-bis[3-(Ethylamino)Propyl]-2-Butene-1,4-Diamine Compounds in Combination with Epigenetic-Acting Pharmaceuticals for Enhanced Cancer TherapyMARTON LAURENCE·Filed 2011·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →